Sara McGahan is a Manager at CBPartners, working across a variety of practices to address a range of commercial business issues.
What’s Next for Alzheimer’s Disease?
9 June 2020
ICER and Pharmaceutical Manufacturers: Allies or Adversaries?
11 September 2019
The Impact of Central and Eastern European (CEE) International Reference Pricing (IRP) Policy Changes
10 July 2019
Parkinson’s Disease Clinical Trials: How Close Are We to Disease-Modifying Therapies?
31 May 2019
Alzheimer’s Disease Clinical Trials: Where Do We Go Now?
30 May 2019
Central Nervous System (CNS) Drug Development Strategy: What is the Role of External Investment in this High-Risk Disease Space?
29 May 2019